文献标引:翟福利，马厚勋.成纤维细胞生长因子23及其基因表达与磷代谢性疾病的关系[J/CD].中华临床医师杂志：电子版,2009,3(12):1991-1996.

参考文献:
[1]　Sitara D，Kim S，Razzaque MS，et al. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet，2008，4（8）：e1000154.[PubMed]
[2]　Shimada T，Kakitani M，Yamazaki Y，et al. Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest，2004，113（4）：561－568.[PubMed]
[3]　Sitara D，Razzaque MS，Hesse M，et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis，and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol，2004，23（7）：421－432.[PubMed]
[4]　Razzaque MS，Lanske B. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol，2007，194（1）：1－10.[PubMed]
[5]　Nakatani T，Sarraj B，Ohnishi M，et al. In vivo genetic evidence for klotho-dependent，fibroblast growth factor 23（Fgf23）-mediated regulation of systemic phosphate homeostasis. FASEB J，2009，23（2）：433－441.[PubMed]
[6]　Urakawa I，Yamazaki Y，Shimada T，et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature，2006，444（7120）：770－774.[PubMed]
[7]　Kurosu H，Ogawa Y，Miyoshi M，et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem，2006，281（10）：6120－6123.[PubMed]
[8]　Ferrari SL，Bonjour JP，Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab，2005，90（3）：1519－1524.[PubMed]
[9]　Gupta A，Winer K，Econs MJ，et al. FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab，2004，89（9）：4489－4492.[PubMed]
[10]　Saito H，Maeda A，Ohtomo S，et al. Circulating FGF-23 is regulated by 1alpha，25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem，2005，280（4）：2543－2549.[PubMed]
[11]　Marsell R，Grundberg E，Krajisnik T，et al. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol，2008，158（1）：125－129.[PubMed]
[12]　Domrongkitchaiporn S，Disthabanchong S，Cheawchanthanakij R，et al. Oral Phosphate Supplementation Corrects Hypophosphatemia and Normalizes Plasma FGF23 and 25-Hydroxyvitamin D3 Levels in Women with Chronic Metabolic Acidosis. Exp Clin Endocrinol Diabetes，2009，May 15. [Epub ahead of print].[PubMed]
[13]　Razzaque MS，Lanske B. Hypervitaminosis D and premature aging：lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med，2006，12（7）：298－305.[PubMed]
[14]　Razzaque MS，Sitara D，Taguchi T，et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J，2006，20（6）：720－722.[PubMed]
[15]　Kuro-o M，Matsumura Y，Aizawa H，et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature，1997，390（6655）：45－51.[PubMed]
[16]　Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens，2006，15（4）：437－441.[PubMed]
[17]　Yu X，Ibrahimi OA，Goetz R，et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology，2005，146（11）：4647－4656.[PubMed]
[18]　Nabeshima Y. Toward a better understanding of Klotho. Sci Aging Knowledge Environ，2006，2006（8）：pe11.[PubMed]
[19]　Gattineni J，Bates C，Twombley K，et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol，2009，297（2）：F282－291.[PubMed]
[20]　ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet，2000，26（3）：345－348.[PubMed]
[21]　Roetzer KM，Varga F，Zwettler E，et al. Novel PHEX mutation associated with hypophosphatemic rickets. Nephron Physiol，2007，106（1）：p8－12.[PubMed]
[22]　Saito T，Nishii Y，Yasuda T，et al. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene. Eur J Endocrinol，2009，161（4）：647－651.[PubMed]
[23]　Imanishi Y，Inaba M，Nakatsuka K，et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int，2004，65（5）：1943－1946.[PubMed]
[24]　Shigematsu T，Kazama JJ，Yamashita T，et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis，2004，44（2）：250－256.[PubMed]
[25]　Gupta A，Winer K，Econs MJ，et al. FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab，2004，89（9）：4489－4492.[PubMed]
[26]　Kusano K，Saito H，Segawa H，et al. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats. Nutr Sci Vitaminol （Tokyo），2009，55（2）：99－105.[PubMed]
[27]　Nagano N，Miyata S，Abe M，et al. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int，2006，69（3）：531－537.[PubMed]
[28]　Westerberg PA，Linde T，Wikström B，et al.Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant，2007，22（11）：3202－3207.[PubMed]
[29]　Garringer HJ，Malekpour M，Esteghamat F，et al. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab，2008，295（4）：E929－937.[PubMed]
[30]　Lammoglia JJ，Mericq V. Familial tumoral calcinosis caused by a novel FGF23 mutation：response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm Res，2009，71（3）：178－184.[PubMed]
[31]　Chefetz I，Kohno K，Izumi H，et al. GALNT3，a gene associated with hyperphosphatemic familial tumoral calcinosis，is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta，2009，1792（1）：61－67.[PubMed]
[32]　Ichikawa S，Sorenson AH，Austin AM，et al. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23（Fgf23）concentrations and hyperphosphatemia despite increased FGF23 expression. Endocrinology，2009，150（6）：2543－2550.[PubMed]